An Overview of Colon Specific Drug Delivery: Approaches and Evaluation Aspects

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Colonic Therapeutics

Background:

• Colon-specific drug delivery systems (CDDS) are crucial for treating colonic disorders such as Inflammatory Bowel Diseases (IBD), amoebiasis, and Colorectal Cancer (CRC).
• Site-specific drug release maximizes therapeutic efficacy at the colon while minimizing systemic exposure and adverse effects in the stomach and small intestine.

Purpose of the Study:

• To review the literature on product development of CDDS.
• To explore various strategies for colon targeting, including pH-dependent, time-dependent, microbial-triggered, and combination approaches.

Main Methods:

• Literature review focusing on recent research in CDDS.
• Analysis of formulation designs, optimization techniques, and targeting strategies.
• Examination of factors influencing colon targeting and evaluation parameters.

Main Results:

• Recent advancements in CDDS design and optimization using novel technologies have been highlighted.
• Various approaches for achieving colon-specific drug release have been discussed.
• The review covers formulation development, targeting strategies, influencing factors, and evaluation methods for CDDS.

Conclusions:

• CDDS are highly advantageous for the targeted delivery of drugs to the colon.
• Effective management of colonic diseases can be achieved through optimized CDDS.
• Novel technologies are continuously improving the design and efficacy of CDDS for colon-specific diseases.